Charleston, SC -- (SBWIRE) -- 10/23/2013 -- Hot Shot Stock Alerts is a market and commodities news and marketing web service, providing investing news, business news, headline news, news alerts, personal finance, stock market, and press releases. Hot Shot Stock Alerts carries you the most fascinating reviews and research reports regarding following stocks: Hercules Offshore, Inc. (NASDAQ:HERO), JinkoSolar Holding Co., Ltd. (NYSE:JKS), Keryx Biopharmaceuticals (NASDAQ:KERX), Kronos Worldwide, Inc. (NYSE:KRO)
Shares of Hercules Offshore, Inc. (NASDAQ:HERO) traded in a range of $7.35 to $7.54, completing the day up +1.42% to $7.51. The total volume of shares exchanged was 2.29 million. The day started out with an opening price of $7.44 versus prior close of $7.41. The company has the total of 159.57 million outstanding shares while its market capitalization is now about $1.20 billion.
Hercules Offshore, Inc., together with its subsidiaries, provides shallow-water drilling and marine services to the oil and natural gas exploration and production industry worldwide. The company operates through five segments: Domestic Offshore, International Offshore, Inland, Domestic Liftboats, and International Liftboats.
Why Should Investors Buy HERO After The Recent Gain? Just Go Here and Find Out
With the latest rise of +4.47%, JinkoSolar Holding Co., Ltd. (NYSE:JKS) now has YTD performance +345.24% which for the week is positive at +17.23%. The total number of shares traded on the latest trading day was about 2.27 million shares, and changed hands at price range of $23.91 to $26.74 apiece. The company ended previous trading at $26.67.
JinkoSolar Holding Co., Ltd., together with its subsidiaries, engages in designing, developing, producing, and marketing photovoltaic products in the People’s Republic of China and internationally.
Will JKS Continue To Move Higher? Find Out Here
Keryx Biopharmaceuticals (NASDAQ:KERX) finished last trade at $10.98, gaining +1.01%. Trading volume recorded for this company was about 2.15 million shares as compared to its average volume of 2.84 million shares. The share price rushed almost +25.34% in the last one month while its 52 week high is $11.90. The company has the total of 81.74 million outstanding shares while its market capitalization is now about $897.51 million.
Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment of renal disease in the United States.
For How Long KERX’s Gloss will Attract Investors? Find out via this report
Kronos Worldwide, Inc. (NYSE:KRO) closed latest trading day at $ 15.78, up +6.26%, on volume of over 2.13 million shares. The stock went up +6.84% in the last 5 days. Its average trading volume is 245,538 shares. In the time frame of the last one month, the share-price has surged/dropped almost +6.84%. Its market capitalization was $1.83 billion.
Kronos Worldwide, Inc. engages in the production and marketing of titanium dioxide pigments (TiO2) primarily in Europe and North America. It produces TiO2 in two crystalline forms, rutile and anatase to impart whiteness, brightness, opacity, and durability for products.
For How Long KRO will Fight for Profitability? Read This Trend Analysis report
The disclaimer is to be read and fully understood before using our site, or joining our newsletter email list.
Never invest into a stock discussed on this web site or the HotShotStockAlerts.com newsletter unless you can afford to lose your entire investment.
Please consult with a certified financial advisor before making any investment decisions.
HotShotStockAlerts.com is owned and operated by FlipVentures LLC. We are engaged in the business of advertising and promoting companies for monetary compensation. All content in our releases is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities.
Read full Disclaimer at: http://hotshotstockalerts.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)